Literature DB >> 20411251

No demonstrable effect of benzathine penicillin on recurrence of rheumatic Fever in pacific island population.

Michael D Seckeler1, Tracey R Hoke, Matthew J Gurka, Leslie L Barton.   

Abstract

Compliance with secondary antibiotic prophylaxis for acute rheumatic fever (ARF) should decrease the rate of recurrence; however, efficacy in a highly endemic area has not been studied. A retrospective chart review of patients <21 years old with a diagnosis of ARF in the Northern Mariana Islands was performed. Patient compliance with benzathine penicillin G (BPG) prophylaxis was assessed. One hundred forty-four patients with ARF were identified and considered eligible, and the recurrence rate was 38%. Mean level of compliance with BPG was 59% in patients with no recurrence of ARF and 57% in patients with recurrence of ARF. Level of compliance was not shown to be associated with odds of recurrence. There was a trend toward significance (p = 0.06), with those patients who had carditis at the time of diagnosis of ARF having higher odds of recurrence. A remarkably high recurrence rate of ARF was found in this population, but there was no difference in compliance with secondary antibiotic prophylaxis between those with and without recurrence of ARF. These findings stress the need to improve methods of primary prevention and secondary antibiotic prophylaxis for ARF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411251     DOI: 10.1007/s00246-010-9718-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

1.  Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G.

Authors:  G H STOLLERMAN; J H RUSOFF; I HIRSCHFELD
Journal:  N Engl J Med       Date:  1955-05-12       Impact factor: 91.245

2.  Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah.

Authors:  L George Veasy; Lloyd Y Tani; Judy A Daly; Kent Korgenski; Lonnie Miner; James Bale; Edward L Kaplan; James M Musser; Harry R Hill
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

3.  Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.

Authors:  Sabry Eissa; Rosemary Lee; Philippa Binns; Gaynor Garstone; Malcolm McDonald
Journal:  Aust N Z J Public Health       Date:  2005-12       Impact factor: 2.939

Review 4.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

5.  The problem of compliance in rheumatic fever.

Authors:  K G Walker; D G Human; M M De Moor; K J Sprenger
Journal:  S Afr Med J       Date:  1987-12-05

6.  Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents.

Authors:  Z M A Meira; E M A Goulart; E A Colosimo; C C C Mota
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

7.  Rheumatic fever prophylaxis: a three-year study.

Authors:  T A Hassell; K L Stuart
Journal:  Br Med J       Date:  1974-04-06

8.  Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever.

Authors:  Guliz Erdem; Carla Mizumoto; David Esaki; Lucienne Abe; Venu Reddy; Paul V Effler
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

9.  Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone.

Authors:  J Carapetis; R Robins-Browne; D Martin; T Shelby-James; G Hogg
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

Review 10.  Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever?

Authors:  B J Currie
Journal:  Pediatrics       Date:  1996-06       Impact factor: 7.124

View more
  7 in total

1.  Benzathine penicillin for recurrence of rheumatic fever: the jury is still out.

Authors:  David A Watkins; Bongani M Mayosil
Journal:  Pediatr Cardiol       Date:  2011-02       Impact factor: 1.655

2.  Secondary prophylaxis is important for the prevention of recurrent rheumatic fever in the Pacific.

Authors:  Andrew C Steer; Samantha Colquhoun; Joseph Kado; Jonathan R Carapetis
Journal:  Pediatr Cardiol       Date:  2011-08       Impact factor: 1.655

3.  Of history, half-truths, and rheumatic fever.

Authors:  Shyam S Kothari
Journal:  Ann Pediatr Cardiol       Date:  2013-07

4.  Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.

Authors:  Priya M Kevat; Benjamin M Reeves; Alan R Ruben; Ronny Gunnarsson
Journal:  Curr Cardiol Rev       Date:  2017

5.  How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.

Authors:  Jessica Langloh de Dassel; Nick de Klerk; Jonathan Rhys Carapetis; Anna P Ralph
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

6.  Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.

Authors:  Brunelle Gasse; Noémie Baroux; Bernard Rouchon; Jean-Michel Meunier; Isabelle De Frémicourt; Eric D'Ortenzio
Journal:  BMC Public Health       Date:  2013-02-12       Impact factor: 3.295

7.  Throat culture positivity rate and antibiotic susceptibility pattern of beta-hemolytic streptococci in children on secondary prophylaxis for rheumatic heart disease.

Authors:  Nigus Zegeye; Daniel Asrat; Yimtubezinash Woldeamanuel; Abebe Habte; Etsegenet Gedlu; Tone Tønjum; Abraham Aseffa
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.